Hebei Changshan Biochemical Hits Day Low at CNY 35.13 Amid Price Pressure

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. experienced a significant decline in its stock price today, dropping by 7.78% and reaching an intraday low of CNY 35.13. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Hebei Changshan has seen a more pronounced decline of 15.59%, and its one-month performance reflects an 18.23% decrease. Year-to-date, the stock has faced a substantial drop of 43.16%, despite a notable increase of 72.2% over the past year. The company’s long-term fundamentals appear weak, with net sales declining at an annual rate of 16.41% and operating profit showing a significant negative trend. The company's financial metrics indicate a high debt-to-equity ratio of 1.54, alongside a return on equity of -19.33%. These factors contribute to a challenging market position within the pharmaceuticals and biotechnology sector, where Hebei Changshan operates as a large-cap entity with a market capitalization of CNY 40,221 million.